Our R&D efforts are guided by a strategic product pipeline. From lab-scale prototyping to scale-up and validation, we ensure that each new formula meets the highest industry standards. Active projects include dexlansoprazole DDR capsules and azithromycin powder for suspension.
Collaborative & Adaptive
We maintain flexibility by working with global partners, contract developers, and MA holders. Our teams integrate market feedback, clinical research, and regulatory updates to shape products that are both commercially and therapeutically valuable.